#3 - MetLife (NYSE:MET)
Investors looking for stability in uncertain times will enjoy the certainty of MetLife (NYSE:MET). The company is the holding company for the Metropolitan Life Insurance Company and its affiliates. This makes it one of the world’s largest insurance providers, annuities, and employee benefit programs. That also means that it will benefit from rising interest rates which should result in improving margins.
This provides a predictable revenue stream which, combined with low capital costs, makes MET stock a solid pick among blue-chip dividend stocks. At the time of this writing, MetLife has an appealing P/E ratio of 7X earnings. Revenue and earnings are expected to grow at low single-digit levels for the next five years. But that shouldn’t be too concerning when dealing with a company offering a dividend yield of 3.25%. Plus, early in 2022, the company increased its dividend for the fifth consecutive year.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More - Current Price
- $82.49
- Consensus Rating
- Buy
- Ratings Breakdown
- 13 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $88.46 (7.2% Upside)
